Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β

D.C.V. is supported by the Fonds de la recherche en sante du Quebec clinician-scientist scholar Junior 2 program. L.D.N. and H.C.S. are supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The Laboratory of Human Genetics of Infectious Diseases is supported by the Howard Hughes Medical Institute, the Rockefeller University, the St. Giles Foundation, the...